Oklo (OKLO) CFO executes options and reports multi-trade sales Sept 2025
Rhea-AI Filing Summary
Oklo Inc. CFO Richard Craig Bealmear reported multiple transactions in Class A common stock on September 17-18, 2025. He exercised two tranches of stock options at an exercise price of $3.18 each, acquiring 100,000 shares on 09/17/2025 and another 100,000 shares on 09/17/2025 (derivative filings show 100,000 options vesting and underlying 100,000 shares each). Following these exercises and subsequent open-market sales, reported holdings of Class A common stock changed across the filings: balances reported include 175,738, 129,535, and 121,913 shares at different points. Sales disclosed include 46,175, 46,203, and 7,622 shares sold at weighted average prices noted between $93.00 and $101.44. The filer certified the Form 4 on 09/19/2025 and provided a footnote that one sale price is a weighted average of multiple executions between $93.00 and $93.11.
Positive
- Option exercise disclosure at a low strike of $3.18 shows realization of long-term compensation aligned with documented vesting.
- Detailed sales pricing provided including a weighted-average range ($93.00–$93.11) and an offer to supply per-trade pricing on request, increasing transparency.
Negative
- Significant open-market sales totaling ~100,000+ shares sold across reported transactions, which materially reduced the reporting person's holdings.
- Multiple post-exercise sales at high market prices ($93–$101.44) could increase available float from insider dispositions, though the filing does not state company context.
Insights
TL;DR: Insider exercised options at a low strike and sold significant shares at market prices above $93, altering direct holdings materially.
The reporting shows option exercises at a $3.18 strike followed by substantial open-market sales executed at prices ranging from $93.00 to $101.44. These transactions increased the reporting person’s direct share count via exercises and then reduced holdings through multiple sales, with post-transaction beneficial ownership figures reported at 175,738, 129,535, and 121,913 shares. For investors, this confirms standard option-to-sale activity by an officer; the sizes of sales relative to reported holdings are material to monitoring insider supply but the filing does not include company-wide context such as total shares outstanding.
TL;DR: Officer disclosed option vesting and multiple sales; documentation includes required explanatory footnotes and signature.
The Form 4 includes necessary disclosures: exercise details including vesting schedule disclosure, weighted-average sale price footnote, and a manual signature dated 09/19/2025. The filing notes the option vested partially earlier (20% vested August 1, 2024) and continues vesting monthly. This filing appears compliant with Section 16 reporting requirements and supplies the issuer or SEC staff with offer to provide transaction-by-transaction pricing breakdowns upon request.